Literature DB >> 28612665

Granular Cell Tumor of the Neurohypophysis With TFE-3 Expression: A Rare Case Report.

Guang-Zhi Yang1, Jing Li1.   

Abstract

Granular cell tumor (GCT) rarely involves the central nervous system, and fewer than 100 cases have been reported in English literatures. We herein report a case of a 36-year-old Chinese man with GCT of the neurohypophysis. Magnetic resonance imaging showed one mass located in the hypophysis with heterogeneous contrast enhancement. Pathological examination showed a neoplasm comprising densely packed polygonal cells of ample cytoplasm with abundant eosinophilic granules inside. The nuclei were small with inconspicuous nucleoli and yet without any mitoses. The tumor was positive for S-100, CD68, CD163, lysosome, and vimentin. Translocation factor E-3 (TFE-3) was diffusely nuclear positive although ASPSCR1-TFE-3 fusion was not detected by fluorescence in situ hybridization. GCT of the neurohypophysis is supposed to be considered under differential diagnosis with neoplasms or lesions of histiocytic origin and others such as pituitocytoma and spindle cell oncocytoma. A group of markers such as GFAP, EMA, CD68, S-100, and PAS staining are useful in complementary diagnosis and TFE-3 may be an alternative marker.

Entities:  

Keywords:  fluorescence in situ hybridization; granular cell tumor; immunohistochemistry; neurohypophysis; translocation factor E-3

Mesh:

Substances:

Year:  2017        PMID: 28612665     DOI: 10.1177/1066896917712861

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  2 in total

Review 1.  Primary tumors of the posterior pituitary: A systematic review.

Authors:  Fernando Guerrero-Pérez; Agustina Pia Marengo; Noemi Vidal; Pedro Iglesias; Carles Villabona
Journal:  Rev Endocr Metab Disord       Date:  2019-06       Impact factor: 6.514

2.  A rare case report of pituicytoma with biphasic pattern and admixed with scattered Herring bodies.

Authors:  Youde Cao; Yan Zeng; Xue Qin; Yiwen Tan; Min Zeng; Lijuan Wang; Xiaojing Cao; Lingfeng Zou; Chenglong Wang
Journal:  World J Surg Oncol       Date:  2020-05-27       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.